Literature DB >> 32532761

Analysis of choriocapillaris perfusion and choroidal layer changes in patients with chronic central serous chorioretinopathy randomised to micropulse laser or photodynamic therapy.

Mary Ho1,2, Frank Hiu Ping Lai3, Danny Siu Chun Ng1, Lawrence Pui Leung Iu1,2, Li Jia Chen1,2, Andrew Chun Yue Mak1,2, Yolanda Yip1, Carol Cheung1, Alvin Lerrmann Young1,2, Marten Brelen4,2.   

Abstract

PURPOSE: The purpose of this study was to investigate the signal changes in choriocapillaris flow deficits and choroidal thickness changes using swept-source optical coherence tomography angiography (OCTA) following different treatments.
DESIGN: A double-blind, randomised controlled trial.
METHODS: Patients with unilateral chronic central serous chorioretinopathy (CSC) were randomised to receive subthreshold micropulse laser therapy (MLT) or half-dose photodynamic therapy (PDT). Choroidal thickness and choriocapillaris flow deficit signals were investigated.
RESULTS: Eighteen patients were randomised into the MLT group and 15 patients into the PDT group. Areas with flow deficit signals were identified in all baseline OCTA images of the choriocapillaris, with mean areas of 0.420 and 0.465 mm2 in the MLT and PDT groups, respectively. These flow deficit signal areas were significantly reduced at 6 months (p=0.011) in the MLT group and at 3 months (p=0.008) in the PDT group. Patients from the PDT group were shown to have smaller flow deficit areas than patients from the MLT group at all time points after treatment (p=0.001, analyses of variance). The mean choroidal volume of the fovea showed a significant reduction at 1 month (p=0.003), 3 months (p=0.199) and 6 months (p=0.006) in the PDT group.
CONCLUSION: The flow deficit areas identified in the choriocapillaris layer may suggest possible relative choroidal ischaemia. With measurement of choroidal volume reduction and faster rates of flow deficit area change, PDT has a stronger effect than MLT in promoting choriocapillaris recovery. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  choroid; imaging; macula; retina

Year:  2020        PMID: 32532761     DOI: 10.1136/bjophthalmol-2020-316076

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

Review 1.  [Statement of the Professional Association of Ophthalmologists in Germany (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on central serous chorioretinopathy : Status 18 October 2021].

Authors: 
Journal:  Ophthalmologe       Date:  2021-12-14       Impact factor: 1.059

2.  OCT biomarkers related to subthreshold micropulse laser treatment effect in central serous chorioretinopathy.

Authors:  Fang Zheng; Jingliang He; Zhitao Su; Ye Liu; Yufeng Xu; Lei Liu; Panpan Ye
Journal:  BMC Ophthalmol       Date:  2022-06-07       Impact factor: 2.086

Review 3.  Statement of the Professional Association of Ophthalmologists in Germany (BVA), the German Society of Ophthalmology (DOG) and the German Retina Society (RG) on central serous chorioretinopathy : Status 18 October 2021.

Authors: 
Journal:  Ophthalmologie       Date:  2022-04-06

Review 4.  Evaluation of the choriocapillaris after photodynamic therapy for chronic central serous chorioretinopathy. A review of optical coherence tomography angiography (OCT-A) studies.

Authors:  Evita Evangelia Christou; Panagiotis Stavrakas; Vassilios Kozobolis; Andreas Katsanos; Ilias Georgalas; Maria Stefaniotou
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-19       Impact factor: 3.117

5.  Comparison of the efficacy and safety of subthreshold micropulse laser with photodynamic therapy for the treatment of chronic central serous chorioretinopathy: A meta-analysis.

Authors:  Zhizhong Wu; Huixing Wang; Junsheng An
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

6.  Influence of Retinal Microsecond Pulse Laser Treatment in Central Serous Chorioretinopathy: A Short-Term Optical Coherence Tomography Angiography Study.

Authors:  Michelle Prasuhn; Yoko Miura; Aysegül Tura; Felix Rommel; Vinodh Kakkassery; Svenja Sonntag; Salvatore Grisanti; Mahdy Ranjbar
Journal:  J Clin Med       Date:  2021-05-29       Impact factor: 4.241

Review 7.  Applications of Multimodal Imaging in Central Serous Chorioretinopathy Evaluation.

Authors:  Mary Ho; Gabriel Li; Andrew Mak; Danny Ng; Lawrence Iu; Frank Lai
Journal:  J Ophthalmol       Date:  2021-07-24       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.